SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John M. Gelnieau who wrote (21624)5/5/1999 9:14:00 AM
From: Mkilloran  Read Replies (1) of 23519
 
John...have another cup of coffee......

Muse (only) distribution rights are granted to Astra/Zeneca and Janssen...They have to cut a deal for new products if they want those rights also (Alibra, Female Sd, Incontinence, etc)

Vivus (does not) have a marketing staff for the USA...it's on auto pilot till they sign a partner that will have the rights to sell Muse and market it as is done overseas.

Japan is still a prize that Vivus has the rights to sell off to a sales/marketing partner like Janssen or Astra/Zeneca...

More good news on it's way soon.....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext